Starting GLP-1Drug While Taking Cancer Medications
- Deborah Ann Martin
- 1 day ago
- 22 min read
Why My Oncologists, Diabetes Team, and Pharmacists Had to Make the Decision Together
When someone has diabetes, starting a new diabetes medicine may sound like a decision between that patient and the doctor treating the diabetes. Then they talk with their pharmacist about the possible side effects.
My situation is more complicated.
I am a Stage IV uterine leiomyosarcoma survivor taking two long-term cancer medicines. I take exemestane because my original tumor was estrogen receptor positive and progesterone receptor positive. I also take lorlatinib because my tumor had an ALK-positive finding.
I have many chronic illnesses. Some are caused by cancer treatments.
I take other medications and vitamins to help with the chronic illnesses
I have a family history of some major medical issues.
Those medicines affect more than the cancer.
They also affect how my doctors must think about every new prescription, over-the-counter medicine, vitamin, supplement, and treatment added to my medical plan.
That is why I could not simply ask my primary-care doctor for Ozempic and begin taking it.
My cancer team, diabetes team, primary-care clinicians, and pharmacists needed to look at the whole picture together.
My Diabetes Was Not Under Control
I was already using several medicines to control my diabetes.
My treatment included insulin, Jardiance, and another diabetes medicine. I believe the third medicine may have been glipizide, but I need to verify the exact name from my medication records before identifying it as part of my permanent cancer history.
I was also paying attention to what I ate.
I limited carbohydrates because they can raise my blood sugar. I tried to make healthier choices and follow the instructions provided by my healthcare professionals.
Even with those efforts and three diabetes medicines, my A1C remained around 7.8 to 8.0.
The treatment plan was helping some, but it was not controlling the diabetes as well as my medical team and I wanted.
What the A1C Test Tells Us
The A1C blood test provides an estimate of a person’s average blood glucose level over the previous 2 to 3 months.
It does not replace daily glucose readings.
It does not show every high or low.
It gives the medical team another piece of the diabetes puzzle.
The best A1C goal is not identical for everyone. A person’s age, health conditions, risk of low blood sugar, medications, life expectancy, and treatment burden may affect the goal selected by the healthcare team.
For me, the repeated A1C results showed that we needed to reconsider what we were doing.
I did not want to continue taking several medicines indefinitely while accepting that the diabetes remained inadequately controlled.
Diet Matters, but Diet Is Not the Entire Explanation
Food choices matter when someone has diabetes. But Food was not causing the high sugar. The cancer medications to slow the progression of my cancer were. Food just escalated the problem.
Carbohydrates can raise blood glucose, and eating patterns can affect A1C, weight, energy, and medication needs.
But it is not fair or medically accurate to assume that every high A1C means the patient is secretly eating badly or refusing to try.
Blood sugar may also be affected by:
* Genetics
* Insulin resistance
* Cancer medicines
* Other prescriptions
* Pain
* Stress
* Sleep
* Illness
* Reduced mobility
* Hormonal changes
* Age
* Weight changes
* The body’s individual response to treatment
I have reduced carbohydrates and made careful food choices, yet still have an A1C around 7.8.
That did not mean lifestyle no longer mattered.
It meant lifestyle changes alone were not enough to solve my problem.
Lorlatinib Changed My Metabolic Health
Soon after I began lorlatinib, my blood sugar rose dramatically.
From my perspective, it felt as though I became diabetic overnight.
Lorlatinib is known to cause new or worsening high blood sugar in some patients. Its official prescribing information also warns about major increases in cholesterol and triglycerides. My doctors monitor these problems as part of my continuing treatment.
I also gained approximately sixty pounds after beginning lorlatinib.
Weight gain is a recognized adverse effect of lorlatinib, although I cannot prove that the medicine was the only cause of every pound I gained. Reduced mobility, pain, diabetes, age, other medicines, activity changes, and additional health factors may also have contributed.
The timing still mattered to me.
My body changed substantially after I began the medication.
I Was Not Asking for a GLP-1Drug While Taking Cancer Medications Just to Lose Weight
GLP-1 medicines are discussed constantly in connection with weight loss.
That was not my primary reason for asking about a GLP-1 drug while taking cancer medications.
I needed better control of my diabetes.
I was taking three diabetes medicines.
I was watching my carbohydrates.
I was trying to eat carefully.
My A1C was still too high for the goal my healthcare team and I were working toward.
Weight loss could potentially help my overall health, mobility, blood pressure, and diabetes management. But I did not begin this process because I wanted a quick or cosmetic way to become thin.
I began it because uncontrolled diabetes can damage the body.
Diabetes Could Add to My Existing Neuropathy
I already live with serious neuropathy.
My hands are affected badly.
At times, the pain in my feet feels like I am stepping on glass.
Lorlatinib can contribute to peripheral neuropathy. Diabetes can also damage nerves.
That means I may have more than one factor affecting the same part of my body.
I cannot remove every risk from my life, but I do not want uncontrolled blood sugar adding more nerve damage to neuropathy that is already difficult to manage.
Getting the diabetes under better control is one way my doctors and I can try to protect the nerves I still have.
Diabetes Can Affect More Than Blood Sugar
Diabetes is not only a high number on a laboratory report.
Over time, poorly controlled blood sugar may contribute to problems involving:
* The eyes
* Feet
* Nerves
* Kidneys
* Heart
* Blood vessels
* Wound healing
* Infection risk
Because I have diabetes, eye examinations have become part of my continuing care.
I also need regular foot evaluation, especially because I already have neuropathy and a history of foot problems.
My cancer treatment had already added specialists to my life.
Diabetes added more.
I Needed a Different Diabetes Plan
I did not want to wait until the diabetes caused more damage before discussing another option.
I began advocating for a change.
That does not mean I demanded a particular medicine and expected my doctors to approve it without review.
I explained that the current combination was not achieving the result we needed.
I asked whether a GLP-1 medicine could be considered.
The question then had to move through several parts of my healthcare team.
What Is a GLP-1 Medicine?
Ozempic is the brand name for injectable semaglutide.
Semaglutide is a GLP-1 receptor agonist. Ozempic is approved to improve blood-glucose control in adults with type 2 diabetes as an addition to diet and exercise. Its current labeling also includes certain cardiovascular and kidney-risk indications for eligible adults with type 2 diabetes.
GLP-1 medicines work through several processes.
They may:
* Help the pancreas release insulin when blood sugar is elevated
* Reduce glucagon, a hormone that can increase blood sugar
* Slow how quickly the stomach empties
* Reduce appetite for some people
* Help improve blood-glucose control
The effects and benefits differ between patients.
Every Medicine Enters the Same Body
Doctors and patients often discuss medications one at a time.
My body does not experience them one at a time.
I take exemestane.
I take lorlatinib.
I use diabetes medicines.
I take thyroid medicine.
I take medicines for blood pressure and cholesterol.
I use vitamins and supplements with the knowledge of my medical team.
Every new medicine joins everything already there.
That means the question is not simply:
“Is Ozempic generally safe?”
The question is:
“How might Ozempic affect this individual patient who has rare cancer, takes two long-term cancer medicines, uses insulin and other diabetes medicines, has hypothyroidism, neuropathy, reduced mobility, and several other health conditions?”
The Diabetes Doctor Could Not Make the Decision Alone
My diabetes clinicians understand blood sugar, A1C, insulin, and diabetes complications.
My cancer doctors understand why I take exemestane and lorlatinib and why changing those medicines is not a simple choice.
The oncology pharmacist understands the known metabolism and interaction concerns connected with cancer drugs.
The primary-care pharmacist can review the full medication list and monitor how the new diabetes plan affects me.
No single member of that team holds every piece.
The decision needed to be collaborative.
I Started With My VA Cancer Team
I discussed the GLP-1 option with the regional cancer clinician who works with me through the VA.
She did not simply say yes or no.
She took the question to the oncology pharmacy team.
They reviewed the proposed medication against my two cancer medicines.
That step mattered because both exemestane and lorlatinib have important interaction considerations.
Lorlatinib has significant interactions involving the CYP3A drug-processing system. Some medicines are contraindicated, while others may require avoidance, dose changes, or additional monitoring.
Strong CYP3A4-inducing medicines may also reduce the body’s exposure to exemestane.
No Known Interaction Does Not Mean No Possible Problem
The oncology pharmacy review did not identify an established direct interaction between Ozempic and exemestane individually or between Ozempic and lorlatinib individually.
That was reassuring.
It was not the same as proving that my complete medication combination had been thoroughly studied.
My cancer is rare.
My use of exemestane and lorlatinib together is highly individualized.
Adding semaglutide creates another combination for which there may not be a large group of patients exactly like me.
The safest wording is:
My team did not find a known direct interaction that automatically prevented me from trying Ozempic. However, the absence of a documented interaction does not guarantee that every effect of my complete combination can be predicted.
That is why monitoring continues after the prescription is approved.
Ozempic Can Slow Stomach Emptying
Semaglutide delays gastric emptying.
In everyday language, it may cause food and oral medicines to remain in the stomach longer before moving through the digestive system.
The FDA prescribing information states that this delay has the potential to affect the absorption of medicines taken by mouth. Clinical studies did not find a clinically relevant effect for every oral medicine studied, but caution and monitoring may still be appropriate.
This matters to me because exemestane and lorlatinib are oral cancer medicines.
It does not prove that Ozempic will prevent either cancer medicine from working.
It explains why my oncology team and pharmacist needed to be involved.
Timing Matters With Many Medicines
I learned about medication timing long before Ozempic.
My thyroid medicine cannot simply be taken whenever I happen to remember it.
Food, supplements, and other medicines may affect how thyroid hormone is absorbed.
That experience taught me an important lesson:
The same list of medicines taken at the wrong times may not behave the same way as a carefully organized schedule.
Now I have morning, afternoon, and nighttime medicines.
I take my cancer drugs at different times of day.
Adding another prescription means checking whether the existing schedule still makes sense.
Over-the-Counter Does Not Mean Interaction-Free
People often assume that medicines sold without a prescription are harmless.
That is not true.
Over-the-counter pain relievers, cold medicines, antacids, allergy medicines, vitamins, minerals, herbal products, and supplements may interact with prescriptions or worsen another health condition.
With my medication list, I need to ask before adding even an ordinary product.
The question may need to go to:
* A pharmacist
* My primary-care team
* My oncology team
* The clinician managing the affected condition
The more complicated the medication list becomes, the less safe it is to assume.
Ozempic and Insulin Require Careful Monitoring
I was already using insulin when Ozempic was added.
The Ozempic prescribing information warns that using semaglutide with insulin or an insulin-secretagogue medicine may increase the risk of hypoglycemia, which means blood sugar becomes too low. Clinicians may need to reduce the dose of insulin or another glucose-lowering medicine as control improves.
If my third diabetes medicine was glipizide, that would be especially relevant because glipizide is a sulfonylurea that encourages the pancreas to release insulin.
I need to verify that medication name before making it part of the final medical record.
The important point remains:
When a new diabetes medicine is added, the old medicines cannot always remain on autopilot.
Low Blood Sugar Has Warning Signs
The symptoms of hypoglycemia can differ, but may include:
* Shaking
* Sweating
* Dizziness
* Weakness
* Sudden hunger
* Confusion
* Irritability
* Fast heartbeat
* Blurred vision
* Difficulty concentrating
Severe low blood sugar may cause loss of consciousness, seizures, or another medical emergency.
My diabetes team must give me the glucose ranges and instructions appropriate for my care.
A blog cannot determine when I should change insulin or another diabetes medicine.
Ozempic Has Its Own Side Effects
Every medicine added to my plan brings possible benefits and possible burdens.
The most commonly reported Ozempic side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation.
The official prescribing information also includes warnings and precautions involving:
* Pancreatitis
* Gallbladder problems
* Kidney injury, sometimes related to dehydration
* Severe gastrointestinal reactions
* Low blood sugar when used with insulin or certain medicines
* Allergic reactions
* Diabetic retinopathy complications in some patients
* Thyroid C-cell tumor findings in animal studies
Not everyone develops these problems.
A listed risk does not mean it will happen to me.
It tells my team and me what needs attention.
I Now Have Another Group of Symptoms to Watch
I already monitor symptoms connected to cancer, exemestane, lorlatinib, diabetes, thyroid disease, asthma, neuropathy, reflux, and chronic pain.
Ozempic adds another layer.
If I develop nausea, diarrhea, stomach pain, reduced appetite, fatigue, or weakness, I cannot automatically assume the cause.
The symptom could be related to:
* Ozempic
* Another medicine
* Low blood sugar
* High blood sugar
* Dehydration
* Cancer treatment
* An infection
* A digestive condition
* Another medical problem
Timing, severity, blood-glucose readings, food intake, fluid intake, and other details may help the medical team evaluate what is happening.
Severe Abdominal Symptoms Need Attention
Severe or persistent abdominal pain should not be ignored, especially when accompanied by vomiting, fever, dehydration, or pain extending toward the back.
Pancreatitis and gallbladder problems are among the serious conditions discussed in the Ozempic prescribing information.
That does not mean ordinary nausea proves a person has pancreatitis.
It means patients should know which symptoms need prompt medical advice or urgent evaluation.
Dehydration Could Affect More Than My Stomach
Nausea, vomiting, or diarrhea can cause dehydration.
Dehydration can affect kidney function, blood pressure, dizziness, weakness, and fall risk.
It may also complicate diabetes management.
For someone already dealing with mobility and balance problems, severe dehydration could create additional danger.
My medical team needs to know if gastrointestinal side effects prevent me from drinking enough fluid or keeping medicines down.
My Eye Care Still Matters
The Ozempic label warns that rapid improvement in blood-glucose control may sometimes be associated with a temporary worsening of diabetic retinopathy in people who already have it. Patients with a history of diabetic retinopathy should be monitored.
I already receive regular eye care because of diabetes.
Starting a GLP-1 medicine does not replace those examinations.
It gives me another reason to report changes such as blurred vision, floaters, dark areas, or sudden changes in sight.
Eye symptoms can have many causes and need professional evaluation.
My Hypothyroidism Is Not the Same as the Boxed Warning
Ozempic carries a boxed warning because semaglutide caused thyroid C-cell tumors in rodents. It is not known whether it causes medullary thyroid carcinoma in humans.
Ozempic is contraindicated in people with a personal or family history of medullary thyroid carcinoma or with multiple endocrine neoplasia syndrome type 2.
I have hypothyroidism.
Hypothyroidism is not the same condition as medullary thyroid carcinoma or MEN2.
Still, every prescriber needs to know my full thyroid history, medication, laboratory results, and symptoms.
A new neck lump, unexplained swelling, trouble swallowing, or a significant new voice change should be discussed with a qualified clinician.
My Existing Voice Problems Make Symptom Tracking Important
I have already developed voice and vocal-cord problems associated with laryngopharyngeal reflux.
That means I cannot automatically connect every period of hoarseness with a new medication.
It also means my doctors need to know what is normal for me and what has changed.
A symptom journal can help distinguish:
* A longstanding problem
* A worsening pattern
* A symptom that began after a dose
* Something requiring another specialist
The more conditions a patient has, the more important the baseline becomes.
The VA Built a Monitoring System Around Me
The VA did more than approve a new medicine.
My regional cancer clinician contacted oncology pharmacy.
The oncology pharmacy reviewed the known interaction concerns.
The diabetes and primary-care teams considered the change in treatment.
A primary-care pharmacist is working with me and monitoring my symptoms, blood-sugar response, and medication plan.
That is the kind of coordinated care I need.
I do not need one doctor to pretend to know everything.
I need the doctors and pharmacists to communicate.
I Started Ozempic on July 24, 2026
I began Ozempic on July 24, 2026.
That date marks the beginning of another medical trial in my life.
At this point, I cannot honestly say whether it will lower my A1C enough.
I cannot say how much weight I may lose.
I cannot say whether my insulin or other diabetes medicines will be reduced.
I cannot say which side effects I may experience.
Those results belong in a future update after my medical team has enough information.
For now, this article documents why we made the change and how we tried to make it responsibly.
Starting Low Is Part of the Plan
Injectable Ozempic is generally begun at a low weekly dose and increased gradually according to its prescribing instructions and the patient’s clinical needs. The initial dose is intended to help the body adjust and is not considered the full maintenance dose for blood-glucose control.
The exact dose, timing, and increases belong to my prescribing team. Starting with smaller doses also helps to determine if there will be any drug interactions.
I should not increase the medicine early because I want faster results.
A gradual plan may help reduce gastrointestinal side effects and give the team time to observe my response.
My Goal Is Better Diabetes Control
The number on the scale matters because excess weight may affect mobility, blood pressure, diabetes, joints, and overall health.
But my central goal is better blood-sugar control.
I want to lower the risk that diabetes will cause more damage to:
* My nerves
* Eyes
* Feet
* Kidneys
* Heart
* Blood vessels
I already have enough health problems to manage.
I do not want preventable diabetes complications added to them.
Weight Loss Could Help My Mobility
I have severe knee problems.
My joints and muscles are affected by chronic pain and stiffness.
I have limited mobility and use a cane, rollator, wheelchair assistance, or store scooter when needed.
Carrying additional weight may make movement more difficult for me.
Losing weight safely could reduce some of the physical burden involved in standing, walking, traveling, and completing daily tasks.
That does not mean weight loss will cure my knee damage, neuropathy, or medication side effects.
It may become one helpful piece of a larger plan.
The VA MOVE! Program Adds Support
The VA MOVE! Weight Management Program is designed to help Veterans work on healthy eating, physical activity, weight, and personal health goals. VA describes it as more than a number on the scale and as a program intended to improve a Veteran’s ability and confidence to manage health.
That matters to me.
I do not need someone to hand me an injection and tell me the rest is my problem.
I need help creating a plan that considers:
* Diabetes
* Cancer treatment
* Mobility
* Pain
* Nutrition
* Activity
* Weight
* Medication effects
* My actual daily life
Exercise Has to Match My Body
I cannot follow an exercise plan written for an able-bodied person who has no cancer history, severe knee damage, neuropathy, chronic stiffness, or balance problems.
My movement plan must consider:
* Bone-on-bone knees
* Fall risk
* Neuropathy
* Spine history
* Pain
* Asthma
* Heart monitoring
* Blood sugar
* Cancer medication effects
* Fatigue
The VA program and my healthcare team can help identify safer ways to move.
Exercise is not helpful when it causes an avoidable injury or makes the patient afraid to continue.
I Can Use the Gym on Base
As a Veteran, I can use the gym at a nearby base.
That gives me access to exercise resources without paying for an outside gym membership.
I am canceling my commercial gym membership and using the Veteran benefit available to me.
That may sound like a small financial decision.
Cancer has made healthcare expensive.
Prescriptions, travel, appointments, supplies, insurance costs, and other needs add up.
Anything medically appropriate that helps me protect my health without adding another monthly bill is valuable.
Free Support Is Still Real Support
People sometimes think free services are less important than services purchased privately.
That is not true.
A no-cost program can provide education, accountability, equipment access, and encouragement.
The important questions are whether the service is appropriate, safe, accessible, and useful.
Using a Veteran benefit is not taking advantage of the system.
The benefit exists to support Veterans’ health.
Medication Does Not Replace Food and Movement
Starting Ozempic does not mean food choices no longer matter.
It does not mean physical activity no longer matters.
It does not mean I can ignore sleep, stress, blood-glucose readings, or follow-up appointments.
Medication is another part of the plan.
My complete diabetes plan may include:
* Ozempic
* Adjusted insulin
* Other diabetes medicine
* Food choices
* Carbohydrate awareness
* Movement adapted to my body
* Weight-management support
* Laboratory work
* Eye care
* Foot care
* Kidney monitoring
* Symptom tracking
No single part carries the whole plan.
Taking More Medicine Is Not Automatically Failure
Some people believe that needing another diabetes medicine means the patient failed especially the GLP-1 drugs.
That belief can create shame.
A body may need additional treatment even when the patient makes meaningful lifestyle changes.
Cancer treatment can change metabolism.
Mobility problems can limit activity.
Pain can disrupt sleep and movement.
Genetics and age may increase insulin resistance.
Adding a medicine is not a punishment.
It is a medical response to the information available.
The Goal Is Not to Stay on Every Medicine Forever
Adding Ozempic does not necessarily mean every existing diabetes medicine will remain unchanged forever.
If glucose control improves, the team may need to adjust insulin or another medication to reduce the risk of low blood sugar.
If side effects become unacceptable, Ozempic may need to be changed or stopped.
If it does not provide enough benefit, the plan may change again.
The medication list should be reviewed rather than allowed to grow automatically.
Every prescription should continue to have a reason.
I Need a Symptom and Glucose Record
The pharmacist cannot monitor what I never report.
I need to track information such as:
* Ozempic dose and date
* Blood-glucose readings
* Low-glucose episodes
* Insulin doses
* Appetite
* Food intake
* Nausea
* Vomiting
* Diarrhea
* Constipation
* Abdominal pain
* Hydration
* Weight changes
* Vision changes
* Neuropathy
* New or worsening symptoms
* Missed medicines
The record does not have to become a perfect diary.
It needs to provide enough information to help the team see patterns.
Questions to Ask Before Starting a GLP-1 With Cancer Medicines
* Why is the GLP-1 medicine being recommended?
* Is the goal blood-sugar control, weight management, cardiovascular protection, kidney protection, or several goals?
* Has my oncology team reviewed it?
* Has an oncology pharmacist checked my cancer medicines?
* Could delayed stomach emptying affect my oral medications?
* Does the GLP-1 have a known interaction with my prescriptions?
* Has my complete combination been studied?
* Which diabetes medicines may need adjustment?
* How often should I check my blood sugar?
* What glucose number is too low for me?
* What symptoms require an urgent call?
* How will my A1C be followed?
* Do I have a history of pancreatitis or gallbladder disease?
* Do I have diabetic retinopathy?
* Do I have a personal or family history of medullary thyroid carcinoma or MEN2?
* Who is coordinating the complete plan?
Questions to Ask the Pharmacist
* What time should I take each oral medicine?
* Should any medicine be separated from food, supplements, or other prescriptions?
* Could semaglutide’s effect on stomach emptying matter for my medications?
* Are there interaction concerns with lorlatinib?
* Are there interaction concerns with exemestane?
* What over-the-counter medicines should I avoid?
* Which vitamins or supplements need review?
* What should I do if I vomit after taking an oral cancer medicine?
* What should I do if I cannot eat or drink?
* Could my insulin or other diabetes medicine cause low blood sugar?
* How should missed doses be handled?
* Which symptoms should be reported immediately?
Questions to Ask During Follow-Up
* Has my average blood sugar improved?
* Has my A1C changed?
* Am I having low-glucose episodes?
* Should insulin be adjusted?
* Do I still need every diabetes medicine?
* Are gastrointestinal effects improving or worsening?
* Am I becoming dehydrated?
* Has my kidney function changed?
* Has my vision changed?
* Is my neuropathy changing?
* Have my cancer-medicine levels or effects raised any concern?
* Is my weight changing at a safe rate?
* Is the current dose still appropriate?
* Does the benefit outweigh the burden?
Loved Ones Should Understand the Real Goal
Family members may hear the word Ozempic and think only about weight loss.
They may ask how many pounds I have lost before asking how my blood sugar is doing.
My reason for taking it is medical.
I need better control of diabetes that remained too high despite several medicines and lifestyle efforts.
Helpful support may include:
* Respecting the medical purpose
* Avoiding comments about body size
* Encouraging hydration according to medical advice
* Watching for low blood sugar or severe illness
* Supporting healthier meals
* Joining safe activities
* Understanding that side effects may require rest
* Helping track symptoms when needed
This is not a beauty project.
It is another part of protecting my health.
What I Wish Someone Had Told Me
I wish others knew that every new medicine would need to be considered through the lens of my cancer treatment.
I wish others knew that “no known interaction” does not mean every combination has been fully studied.
I wish others knew explained how a GLP-1 medicine could affect stomach emptying and potentially influence oral medicines.
I wish more people understood that a high A1C is not always proof that a patient refuses to eat well.
I wish someone had said that taking several diabetes medicines without reaching the needed control was a valid reason to reconsider the plan.
I wish people understood that I was not asking for Ozempic simply because I had gained weight.
Most of all, I wish every patient taking cancer medicine were told:
“Before adding any prescription, over-the-counter medicine, vitamin, or supplement, make sure your oncology team and pharmacist know. The medicine does not enter an empty body. It joins everything already there.”
Hope for Today
I began Ozempic on July 24, 2026.
I do not yet know what the final outcome will be.
I hope my A1C improves.
I hope my diabetes becomes easier to control.
I hope protecting my blood sugar helps reduce the risk of more damage to my nerves, eyes, feet, kidneys, heart, and blood vessels.
I also hope I lose some of the weight I gained during years of cancer treatment and reduced mobility.
But I did not begin this medicine alone.
I started by speaking with my VA cancer clinician.
She involved the oncology pharmacy team.
They reviewed exemestane and lorlatinib.
My diabetes and primary-care teams remained part of the decision.
A primary-care pharmacist is monitoring how my body responds.
The VA MOVE! program is helping address nutrition, activity, weight, and overall health.
I can use a nearby base gym without adding another monthly bill to the financial cost of surviving cancer.
This is what coordinated care should look like.
No one looked only at the A1C.
No one looked only at the cancer.
No one looked only at my weight.
They looked at the person carrying all three.
Ozempic is not a miracle answer.
It is another tool.
My cancer medicines are not ordinary background prescriptions.
They are part of every future medication decision.
My pharmacists are not simply people who place pills into bottles.
They help protect me from interactions and medication mistakes.
My laboratory results are not random numbers.
They show my doctors when a plan is not working well enough.
My role is not to stay silent and hope someone notices.
My role is to keep records, report symptoms, ask questions, and make sure the different parts of my medical team communicate.
I am not taking Ozempic because I failed.
I am taking it because the information showed that my previous plan needed to change.
Frequently Asked Questions
What is Ozempic?
Ozempic is a brand name for injectable semaglutide, a GLP-1 receptor agonist used to improve blood-glucose control in eligible adults with type 2 diabetes.
Is Ozempic only a weight-loss medicine?
Ozempic is approved for type 2 diabetes and certain related cardiovascular and kidney-risk indications. Semaglutide is also available under other product names and doses for different approved uses.
Can someone take Ozempic while receiving cancer treatment?
That decision must be individualized. The oncology team, diabetes clinician, and pharmacist should review the cancer treatment, full medication list, health history, and potential risks.
Does Ozempic have a known direct interaction with exemestane or lorlatinib?
My oncology pharmacy team did not find a known direct interaction that prevented my trial. That does not guarantee that every effect of the complete combination has been studied or can be predicted.
Why does delayed stomach emptying matter?
Ozempic can delay gastric emptying, which has the potential to affect how oral medicines are absorbed. The clinical importance differs by medicine and patient.
Can Ozempic cause low blood sugar?
Ozempic alone has a lower risk of hypoglycemia than insulin, but the risk increases when it is used with insulin or certain medicines that stimulate insulin release.
Why was I interested in a GLP-1 medicine?
My A1C remained around 7.8 to 8.0 despite insulin, Jardiance, another diabetes medicine, reduced carbohydrates, and healthier food choices. I wanted better diabetes control.
Was weight loss part of the goal?
Yes, but it was not the primary reason. Better blood-sugar control and reducing the risk of diabetes complications were my main goals.
Does hypothyroidism mean someone cannot take Ozempic?
Not automatically. The boxed warning concerns medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2, which are different from ordinary hypothyroidism. The prescribing clinician should review the person’s complete thyroid history.
What are common Ozempic side effects?
Common effects include nausea, vomiting, diarrhea, abdominal pain, and constipation. Serious risks and the complete safety information should be reviewed with the prescriber and pharmacist.
Should a patient stop insulin after starting Ozempic?
No medication should be stopped or changed without instructions from the prescribing team. Insulin or other diabetes medicines may need adjustment as glucose levels change.
What is the VA MOVE! program?
MOVE! is a VA weight-management and health program that supports Veterans with nutrition, physical activity, weight, and personal health goals.
Support on Your Journey
Managing diabetes during cancer treatment can feel like adding another full-time job.
You may be watching blood sugar, A1C, food, neuropathy, cancer medicines, insulin, side effects, laboratory work, and several doctors at the same time.
Surviving Life Lessons Community Groups are being formed so people can discuss cancer treatment, diabetes, medication burden, weight changes, chronic illness, and the emotional work involved in managing several conditions at once.
Neighbor Chat offers a relaxed, one-on-one place to talk when you need someone to understand that another prescription is not a simple decision.
Next Step Coaching can help someone organize a medication list, symptom record, laboratory questions, and the next conversation to have with the appropriate healthcare professional. It does not replace oncology, pharmacy, endocrinology, primary care, nutrition, diabetes education, or other qualified professional services.
Every doctor may hold one piece of your healthcare puzzle.
You deserve a team willing to put those pieces together.
Find Your Community
No one should have to face life's challenges alone. At Surviving Life Lessons, we believe in life survivors helping life strugglers. Explore our growing Community Groups to connect with others who understand your journey, share encouragement, and find hope through meaningful conversations. You'll also have the opportunity to introduce yourself and share your own story of overcoming. Your story matters. It may be the encouragement someone else needs to keep moving forward, reminding them that they are not alone and that hope is always possible.
Need More Personalized Support?
Everyone's journey is unique. If you're looking for personalized guidance, encouragement, or one-on-one support, explore our services to find the option that's right for you. We're here to help you take your next step with confidence and hope.
Helpful Resources for Your Journey
Explore our collection of books, journals, coloring books, and printable PDFs designed to encourage, inspire, and support you every step of the way.
References
## Trusted References
**U.S. Food and Drug Administration. “Ozempic® (Semaglutide) Injection Prescribing Information.” Revised June 2026.**
**Pfizer. “LORBRENA® (Lorlatinib) Full Prescribing Information.”**
**Pfizer. “LORBRENA® Patient Information.”**
**Pfizer. “AROMASIN® (Exemestane) Full Prescribing Information.”**
**MedlinePlus. “Lorlatinib.”**
**U.S. Department of Veterans Affairs. “MOVE! Weight Management Program.”**
**U.S. Department of Veterans Affairs. “Get Started With MOVE!”**
**U.S. Department of Veterans Affairs. “MOVE! Coach.”**
---
**Disclaimer:** This article shares my personal experience and general educational information. It is not medical, oncology, diabetes, pharmacy, nutrition, thyroid, exercise, or weight-management advice. Ozempic, insulin, Jardiance, lorlatinib, exemestane, and other medicines affect people differently. No medication should be started, stopped, held, increased, reduced, or rescheduled without instructions from qualified healthcare professionals who understand the patient’s complete medical history and medication list. Seek urgent medical care for severe abdominal pain, repeated vomiting, serious dehydration, severe low blood sugar, breathing problems, allergic symptoms, sudden vision changes, or other emergency symptoms.
About the Author:
Deborah Ann Martin is the founder of Surviving Life Lessons, a published author, poet, speaker, and trainer with over 20 years of management experience across multiple industries. An MBA graduate, U.S. veteran, single mother, and rare cancer survivor, Deborah brings both professional expertise and lived experience to her writing on resilience, leadership, personal growth, and overcoming adversity. Her mission is to empower others with practical wisdom and real-life insight to navigate life’s challenges with strength and purpose.
.png){kind=small}
Comments